Canagliflogin | B1597

Canagliflozin is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2), that belongs to a new class of anti-hyperglycaemic agents used in type 2 diabetes mellitus (T2DM).

Canagliflozin is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2), that belongs to a new class of anti-hyperglycaemic agents used in type 2 diabetes mellitus (T2DM).

B1597 | Canagliflogin DataSheet

Alternate Name/Synonyms: (3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

Appearance: White solid

Formulation: N/A

CAS Number: 842133-18-0

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: N/A

Molecular Formula: C₂₄H₂₅FO₅S

Molecular Weight: 444.52

Cell-Permeable?: Yes

Purity: ≥98%

Solubilities: DMSO

Handling: Protect from air and moisture

Country of Origin: USA

Tag Line: A subtype 2 sodium-glucose transport protein (SGLT2) inhibitor

MDL Number: N/A

PubChem CID: 24812758

SMILES: CC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F

InChi: InChI=1S/C24H25FO5S/c1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14/h2-10,19,21-24,26-29H,11-12H2,1H3/t19-,21-,22+,23-,24+/m1/s1

InChi Key: XTNGUQKDFGDXSJ-ZXGKGEBGSA-N